Chao Zhong

Chao Zhong is a researcher-turned-founder who launched PAM2L Biotechnologies (柏垠生物) in March 2021, drawing on his background at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, where he held a National Outstanding Young Scientist Fund award . The company applies a dual-engine approach combining synthetic biology and machine learning to develop bio-based materials and medical products, with core pipelines in adhesive proteins, bacterial cellulose, and mucopolysaccharides . In a 2023 interview with 暗涌Waves, Zhong described the sharp transition from academia to entrepreneurship, noting that while research operates toward conclusions and results, company decisions require fully market-driven logic—adding that understanding both systems simultaneously is rare . He co-founded the firm with university classmate Cui Junfeng, and the founding team included multiple PhDs with top-tier global academic credentials alongside seasoned process engineering experts .